G31.0

Frontotemporal Dementia (ICD-10-CM G31.0)

Focused guidance for Frontotemporal dementia under code G31.0, designed to support clear triage language and continuity of neurological care.

Sam Tuffun , PT, DPT
Expertise in rehabilitation, outpatient care, and the intricacies of medical coding and billing.

Overview

Frontotemporal Dementia (G31.0) is less about labeling a chart and more about connecting pattern recognition to safe next actions, in a way that supports decisions for G31.0.

The most useful notes describe what changed since the prior encounter, what remains uncertain, and what would trigger re-evaluation, in a way that supports decisions for G31.0.

Concise, evidence-linked wording usually outperforms broad narrative for safety and billing alignment, which is particularly relevant in active management of G31.0.

This content is educational and should complement, not replace, urgent triage pathways or specialist judgment, in a way that supports decisions for G31.0.

Symptoms

Ask what changed first, what changed most recently, and what the patient considers the main current limitation, which often changes next-visit planning for G31.0.

Functional impact on driving, work, school, or self-care should be documented as a clinical outcome, not a side note, something that usually alters follow-up cadence in G31.0.

For G31.0, symptom review should capture onset speed, progression pattern, and impact on routine activities, a practical triage signal within other degenerative diseases of the nervous system (g30-g32) for G31.0.

Record severity shifts across day/night cycles, stress load, medication timing, and sleep quality, something that usually alters follow-up cadence in G31.0.

Causes

Primary neurologic mechanisms may coexist with metabolic, medication, vascular, inflammatory, or infectious contributors, and helpful for safer handoff notes linked to G31.0.

In recurrent presentations, compare the current pattern to historical baseline rather than treating each event as isolated, a detail that improves chart clarity for G31.0.

Likely causes for G31.0 should be ranked by plausibility and consequence, not listed as an unprioritized checklist, especially useful when counseling patients about G31.0.

Previous episodes and prior treatment response often narrow etiology faster than broad testing alone, especially useful when counseling patients about G31.0.

Diagnosis

Begin with focused history and neurologic exam, then expand testing when results will change action, a practical triage signal within other degenerative diseases of the nervous system (g30-g32) for G31.0.

Chart quality improves when ordered and non-ordered investigations are both explained, a practical triage signal within other degenerative diseases of the nervous system (g30-g32) for G31.0.

When tests are deferred, include rationale and explicit criteria for when testing should be revisited, which often changes next-visit planning for G31.0.

Diagnostic strategy for G31.0 should answer clear clinical questions tied to immediate management decisions, which often changes next-visit planning for G31.0.

Differential Diagnosis

In evolving presentations, serial differential updates are usually safer than premature closure, something that usually alters follow-up cadence in G31.0.

A transparent differential note supports better handoffs across ED, inpatient, and outpatient settings, something that usually alters follow-up cadence in G31.0.

State why key alternatives were deprioritized; this improves both safety and audit defensibility, a practical triage signal within other degenerative diseases of the nervous system (g30-g32) for G31.0.

Differential diagnosis for G31.0 should balance probability with harm if a diagnosis is missed, a practical triage signal within other degenerative diseases of the nervous system (g30-g32) for G31.0.

Prevention

Early response to small warning changes can prevent high-cost emergency escalations, which often changes next-visit planning for G31.0.

Prevention improves when responsibilities are explicit for patient, caregiver, and clinical team, something that usually alters follow-up cadence in G31.0.

Written action plans outperform verbal-only guidance when symptoms recur between visits, and helpful for safer handoff notes linked to G31.0.

For this profile, prevention priority is trigger management with realistic behavior planning, and helpful for safer handoff notes linked to G31.0.

Prognosis

The most useful prognosis metric here is quality-of-life impact over the next 3 to 6 months, something that usually alters follow-up cadence in G31.0.

Objective milestones should guide reassessment frequency and treatment adjustments, which often changes next-visit planning for G31.0.

Patients usually do better when expected recovery windows and uncertainty are both explained clearly, especially useful when counseling patients about G31.0.

Prognosis in G31.0 depends on etiology, baseline reserve, treatment timing, and follow-up continuity, a practical triage signal within other degenerative diseases of the nervous system (g30-g32) for G31.0.

Red Flags

Outpatient worsening with repeated falls, confusion, or severe headache needs expedited evaluation, especially useful when counseling patients about G31.0.

If high-risk signs appear, delay in escalation can be more harmful than over-triage, and helpful for safer handoff notes linked to G31.0.

Sudden severe symptom change from baseline should trigger urgent reassessment rather than routine follow-up, and helpful for safer handoff notes linked to G31.0.

Escalate urgently for altered consciousness, new focal deficits, persistent vomiting, or rapidly progressive weakness, something that usually alters follow-up cadence in G31.0.

Risk Factors

Social determinants such as transport limits, fragmented care, or low support at home can increase adverse-event risk, which often changes next-visit planning for G31.0.

Risk documentation is most useful when linked directly to monitoring interval and escalation thresholds, a detail that improves chart clarity for G31.0.

If recent hospitalization or medication change occurred, reassess risk before keeping prior follow-up cadence, a detail that improves chart clarity for G31.0.

Polypharmacy and adherence barriers can shift risk more than diagnosis label alone, something that usually alters follow-up cadence in G31.0.

Treatment

Treatment planning for G31.0 should define goals, expected trajectory, and pre-set checkpoints for modification, a detail that improves chart clarity for G31.0.

Medication choices should reflect symptom pattern, comorbidity profile, and tolerability history, something that usually alters follow-up cadence in G31.0.

Document what success looks like at 2 weeks, 6 weeks, and next follow-up interval, something that usually alters follow-up cadence in G31.0.

At discharge, teach-back can reveal misunderstandings before they become safety events, which often changes next-visit planning for G31.0.

Medical References

NINDS overview relevant to Frontotemporal dementia (coding variant G 31 0)
CDC prevention and safety resources for Other degenerative diseases of the nervous system (G30-G32) in Frontotemporal dementia presentations (coding variant G 31 0)
WHO ICD-10 classification notes for Frontotemporal dementia and related diagnoses (variant G 31 0)
AHRQ documentation and care-transition guidance for Frontotemporal dementia in neurology workflows (coding variant G 31 0)
Specialty society guidance for clinical management of Frontotemporal dementia with Other degenerative diseases of the nervous system (G30-G32) context (coding variant G 31 0)

Got questions? We’ve got answers.

Need more help? Reach out to us.

What does ICD-10-CM code G31.0 represent in plain language? (Frontotemporal Dementia; coding variant G 31 0)
When is additional testing justified? (Frontotemporal Dementia; coding variant G 31 0)
What should follow-up planning include after diagnosis? (Frontotemporal Dementia; coding variant G 31 0)
What chart details make documentation stronger for this code? (Frontotemporal Dementia; coding variant G 31 0)
What should patients and caregivers watch for at home? (Frontotemporal Dementia; coding variant G 31 0)